AstraZeneca(AZN)
Search documents
AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN
ACCESSWIRE Newsroom· 2025-01-17 16:00
AstraZeneca PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN ...
Investors in AstraZeneca PLC Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN
ACCESSWIRE Newsroom· 2025-01-17 14:15
Core Viewpoint - Investors in AstraZeneca PLC are encouraged to contact Levi & Korsinsky before February 21, 2025, to discuss their rights regarding potential legal actions related to the company [1] Group 1 - The announcement highlights the importance of timely communication for investors who may have claims against AstraZeneca [1] - The deadline for contacting the law firm is set for February 21, 2025, indicating a specific timeframe for potential legal recourse [1] - The notice serves as a reminder for investors to be proactive in understanding their rights and options concerning their investments in AstraZeneca [1]
AZN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
ACCESSWIRE Newsroom· 2025-01-17 12:00
AZN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! ...
AstraZeneca PLC Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - AZN
Prnewswire· 2025-01-17 10:45
NEW YORK, Jan. 17, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AstraZeneca investors who were adversely affected by alleged securities fraud between February 23, 2022 and December 17, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/astrazeneca-plc-lawsuit ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines – AZN
ACCESSWIRE Newsroom· 2025-01-17 01:45
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines – AZN ...
Levi & Korsinsky Notifies Shareholders of AstraZeneca PLC (AZN) of a Class Action Lawsuit and an Upcoming Deadline
ACCESSWIRE Newsroom· 2025-01-16 23:15
Levi & Korsinsky Notifies Shareholders of AstraZeneca PLC (AZN) of a Class Action Lawsuit and an Upcoming Deadline ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
ACCESSWIRE Newsroom· 2025-01-16 19:00
Core Viewpoint - The Pomerantz Law Firm is reminding shareholders of AstraZeneca PLC about a class action lawsuit related to investment losses, highlighting upcoming deadlines for participation in the lawsuit [1] Group 1 - The law firm is specifically targeting shareholders who have incurred losses on their investments in AstraZeneca PLC [1] - The announcement emphasizes the importance of the upcoming deadlines for shareholders to join the class action lawsuit [1] - The firm is actively seeking to represent affected shareholders in the legal proceedings against AstraZeneca [1]
Contact Levi & Korsinsky by February 21, 2025 Deadline to Join Class Action Against AstraZeneca PLC (AZN)
GlobeNewswire News Room· 2025-01-16 18:54
NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AstraZeneca investors who were adversely affected by alleged securities fraud between February 23, 2022 and December 17, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/astrazeneca-plc-l ...
AstraZeneca PLC Is Being Sued For Securities Law Violations And Impacted Shareholders Are Urged To Contact The Schall Law Firm
ACCESSWIRE Newsroom· 2025-01-16 15:45
AstraZeneca PLC Is Being Sued For Securities Law Violations And Impacted Shareholders Are Urged To Contact The Schall Law Firm ...
AstraZeneca (AZN) Reels from China Investigation and Investor Suit–Hagens Berman
GlobeNewswire News Room· 2025-01-15 19:13
SAN FRANCISCO, Jan. 15, 2025 (GLOBE NEWSWIRE) -- AstraZeneca (NASDAQ: AZN), the Anglo-Swedish pharmaceutical giant, has seen its stock price tumble 15 percent over the past six months, buffeted by a series of unsettling reports emanating from China. A widening investigation by China regulators into alleged illegal drug imports, data breaches, and potential health insurance fraud has cast a shadow over the company’s prospects in a critical market, triggering a securities class action lawsuit in the United St ...